Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt
NCT02247401
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
HCV
Hepatitis C Infection
Genotype 4
Interventions
DRUG:
2 DAA
DRUG:
RBV
Sponsor
AbbVie